Arbutus Biopharma Corporation ABUS Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Arbutus Biopharma Corporation’s reported figures.
Based on the most recent quarter.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's current ratio?
- Arbutus Biopharma Corporation (ABUS) reported current ratio of 54.3× in Q1 2026.
- How has Arbutus Biopharma Corporation's current ratio changed year-over-year?
- Arbutus Biopharma Corporation's current ratio increased by 802.7% year-over-year, from 6× to 54.3×.
- What is the long-term trend for Arbutus Biopharma Corporation's current ratio?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's current ratio has grown at a 3.3% compound annual growth rate (CAGR), from 13.4× to 15.7×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.